Hey PS...been awhile..focusing on INMG-*THE MOST IMPORTANT

New Post Public Reply Private Reply Replies (0) Message Board
stockfalcon PoemStone #52824
333
Hey PS...been awhile..focusing on INMG- *THE MOST IMPORTANT FACT: All Preferred B shares are extinguished so that dilution/conversion can NO longer happen meaning..So those waiting for the MARKET SHARE ORDER BIG DUMP DIPS OF THE PREFERRED B SHARES are cut off from getting in at lower levels....THAT INCLUDED THE MMS too that USED them to COVER their SHORTS in the PAST.. IT CANT AND WONT HAPPEN AGAIN-THEY ARE ALL GONE and was the SINGLE MOST DESTRUCTIVE FORCE on the PPS and we know that any deals Tom is putting in place are for RESTRICTED SHARE WITH A MINIMUM 1YR OUT SUBJECT TO RULE 144.
This means. *Our 172 M float is going to REMAIN UNCHANGED TILL JUNE/JULY 2018....and I can list MJ Sector stocks in the with Float 5 times larger that trade .10-.20+ range and are not only having much bigger floats but also huge debt/liabilities as well IN THE MILLIONS$ UNLIKE INMG WITH ONLY $90K. ALL UNLIKE INMG now!...read the new blog below to learn all about this and much more...good factual stuff...If these stock can hit .10-.20+ THERE IS NO REASON IN THE WORLD INMG CANT EITHER WITH VOLUME...ITS A ONE OF A KIND STOCK...YOU CANNOT INVEST IN ANOTHER CANNABIS NETWORK/CHANNEL ANYWHERE...PERIOD. THIS STOCK CAN BE SO MUCH MORE THAN THE VALUE AT THESE LEVELS...MUCH MUCH MORE WITH THE LOW FLOAT, ALMOST PROFITABLE ALREADY, EXTREMELY LOW DEBT/LIABILITIES AND LOW OVERHEAD, AND THE BOOM CANNABIS SECTOR THAT ALL NEED AT OUTLET TO ADVERTISE THEIR PRODUCTS & SERVICES.

*ALL MUST READ THIS NEW BLOG OUT 11/22 INMG talks about these PREFERRED B SHARES AND MUCH MORE: CannaNet.tv to Make Historic Network Launch in the Cannabis Space

http://ownthefloat.com/index.php/2017/11/22/i...bis-space/

INMG is almost PROFITABLE ALREADY....only a $12k loss in Q3 ( Rev- Operating expenses) HOW MANY OTC COMPANIES ARE PROFITABLE, VERY FEW OR NONE...INMG has VERY LITTLE DEBT/LIABILITIES and a small locked FLOAT till mid 2018...HOW MANY OTC companies can say that? NONE except INMG ....WITH THE LOW OVERHEAD TO MAINTAIN THE NETWORK because most is out sourced, its doesnt take much money to operate it. Tom, expects the CASH flow alone from advertising to cover it, and I have NO DOUBT that it will and quickly like Q1 2018 the latest become PROFITABLE....VERY PROFITABLE...They earned $58k in rev. last quarter and the Cannanet.Tv wast not even up yet...was mostly from Live Stream Sales & Lux DIgiital Library. The Operating Expenses were only $70k...thats was mostly due to LIVE STREAM COSTS...and the company was ALMOST PROFITABLE ALREADY....Only a $12k LOSS for the quarter....GO LOOK AT THESE MJ STOCKS WITH $50-100M Market caps....they have HUGE LOSSES and NO REVs for the most part....Are market cap of INMG is $3M and a JOKE...should be much higher....it will get there....A PPS OF .40 would support MC of a $50M which would be inline with the sector.
INMG from the latest Quarterly: (Q3)

Total Assets : $2,700,000
Total Current Liabilities: $90,000
Q3 Revenue: $58,000
Total Operating Expenses: $70,000
Net Loss for the Q3 -$12,000
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Changshan's Tourism Boom: 22.8% Increase Over Holiday

Updated Category News Views 88

Changshan Grabs Attention This National Day You know, I blinked twice when I saw Changshan's tourist numbers this year. During the 2026 National Day holiday, they managed to snag 503,000 visitors. That's up by a whopping 22.8% from last year. If that doesn't grab your attention, I don't know what will. We're talking record numbers here, folks, and that's the kind of...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 51

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
VeriSilicon's GCNanoOptimaV Transforms Wearable Tech

Updated Category News Views 105

Revving Up Wearables with Next-Gen Graphics Well, folks, VeriSilicon's at it again, rolling out some cutting-edge technology in the form of their spanking new GCNanoOptimaV GPU IP. If you're scratching your head wondering what this means for your wrist-bound gadgets, hang tight—I'm about to spell it out. Architectural Innovations: Striking the Balance Here's the scoop...

Continue Reading
Jungbunzlauer Introduces Johan Westman to Its Board

Updated Category News Views 35

A Strategic Addition to Jungbunzlauer’s Board In what feels like a significant move, Jungbunzlauer has roped in Johan Westman to join its Board of Directors. The man’s got pedigree—a CEO at AAK AB, a Swedish powerhouse dealing in plant-based oils, he's taking a seat at Jungbunzlauer’s table. So, what does this mean for Jungbunzlauer? Well, the potential for...

Continue Reading
Taiwantrade Introduces AI Sourcing Assistant: ASTRA

Updated Category News Views 121

Revolutionizing AI-Powered Global Sourcing Here's the scoop from Taipei: Taiwantrade's just dropped ASTRA, their brand-spanking-new AI sourcing assistant, and it's got the industry buzzing. When it comes to cutting through the clutter and finding the right supplier, this could change the game for how international buyers scrape deals out of Taiwan. Simplifying Complex...

Continue Reading
APEC CEO Summit Marries Innovation and Global Ties

Updated Category News Views 21

Shenzhen: The Heartbeat of Future Business Shenzhen isn't just a city on the map. It's an exploding innovation powerhouse, a place where global business leaders will rub shoulders this November for the 2026 APEC CEO Summit. This ain't your average conference, my friends. CCPIT (China's national trade pushers) are hosting it from November 17 to 18, promising a powerhouse...

Continue Reading
AAN Seeks Donations to Drive Crucial Brain Research

Updated Category News Views 101

Boosting Brain Horizons: The Need for Donations Urgency clings to the air like smoke around a campfire when it comes to funding brain research. The American Academy of Neurology (AAN) knows this, and they've kicked off their year-end giving campaign, trying to rope in every penny they can muster for the AAN Research Program. With brain diseases lining up like unwanted...

Continue Reading
Seniors and Cybersecurity: Tackling Holiday Threats

Updated Category News Views 90

Battle Against the Holiday Cyber Threats This ain't just about slipping on an ugly sweater this holiday season. The ugly truth is as the colder weather rolls around, so do the cyber vultures—praying on the unsuspecting, especially our seniors. Fraudsters are cranking up the heat, exploiting online shopping sprees, hefty travel plans, and even the warm embrace of a...

Continue Reading
KT&G Soars with Record Profits, Aggressive Share Buybacks

Updated Category News Views 73

KT&G Climbs to New Heights with Record-Setting Q3 If you're eyeballing the markets like a hawk, KT&G (KRX: 033780) just gave you something to squawk about. In the world of stocks, milestones are few and far between, but KT&G is handing out milestones like candy in Q3. They rolled out their numbers for the quarter, and let me tell ya, this was no pie-in-the-sky nonsense....

Continue Reading
New Player in Options Trading: Mercury Alerts Launches

Updated Category News Views 28

Enter Mercury Alerts in a Changing Trading Landscape Damn, if there ain't some days that throw us a curveball, today's one of them. Since Cboe pulled the plug on the beloved Trade Alert, it's like chopping off a trader's lifeline without a backup. Just when everyone was getting cozy with the way Trade Alert fed the options flow into our screens, here comes Harmeet Goindi...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Upcoming Class Action Against Walgreens for WBA Shareholders

Updated Category News Views 146

Join the Upcoming Class Action Against Walgreens for WBA Shareholders The Gross Law Firm has issued an important notice for shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) regarding a potential class action lawsuit. If you purchased shares of WBA within the specified dates, you may want to consider your options for participation. Class Action Overview This...

Continue Reading
US Employment Surge Sparks Optimism in Asian Markets

Updated Category News Views 187

US Employment Surge Sparks Optimism in Asian Markets By Jamie McGeever As Asian markets prepare to open, the global economic landscape is shifting dramatically, spurred by astonishing U.S. employment figures. This unexpected data has shifted market perceptions and prompted investors to reconsider their strategies. Strong September Non-Farm Payrolls Report The report on...

Continue Reading
Block, Inc. Investors Urged to Connect with Legal Support Now

Updated Category News Views 161

Understanding Your Rights as a Block, Inc. Investor For investors of Block, Inc. looking to recover their losses, it's crucial to understand the legal avenues available to them. The recent issues surrounding Block should encourage affected investors to seek assistance promptly. How to Recover Losses The Portnoy Law Firm is available to help investors navigate the...

Continue Reading
Key Takeaways from Implantica AG's Annual General Meeting

Updated Category News Views 204

Highlights from Implantica AG's Annual General Meeting On a recent date, the annual general meeting (AGM) of Implantica AG (publ) took place in Ruggell. This important gathering allowed shareholders to review key proposals and resolutions put forth by the board of directors, all of which were adopted. Below is a detailed overview of the notable decisions made during this...

Continue Reading
BRIUMVI's 5-Year Trials Show Significant Efficacy and Safety

Updated Category News Views 116

Key Findings from BRIUMVI's 5-Year Trials TG Therapeutics, Inc. (NASDAQ:TGTX) has revealed impressive results from its long-term Phase 3 trials, ULTIMATE I & II, which focus on BRIUMVI (ublituximab-xiiy) for treating relapsing forms of multiple sclerosis (RMS). These findings were presented at the respected European Committee for Treatment and Research in Multiple...

Continue Reading